SLNO

Soleno Therapeutics (SLNO)

Soleno Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SLNO

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/09/17	05:05	GlobeNewswire Inc.	Soleno Therapeutics to Present at 2024 Cantor Global Healthcare Conference	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/09/11	07:30	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/09/06	07:37	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/08/31	07:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/08/31	07:34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/08/31	07:33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/08/30	08:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/08/27	21:00	GlobeNewswire Inc.	Soleno Therapeutics Announces U.S. FDA Acceptance for Filing and Priority Review of NDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/08/24	08:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/08/24	08:14	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/08/20	05:17	GlobeNewswire Inc.	Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/08/17	07:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/08/17	07:16	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/08/16	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/08/15	21:00	GlobeNewswire Inc.	Soleno Therapeutics Announces Updates to its Board of Directors	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/08/08	07:57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/08/08	07:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/08/08	07:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/08/08	06:18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/08/08	05:05	GlobeNewswire Inc.	Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/08/08	05:00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/07/20	06:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/07/20	06:02	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/07/19	22:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/07/19	22:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/07/19	22:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/07/19	22:02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/07/19	22:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/07/19	22:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SLNO	Soleno Therapeutics Inc
2024/06/28	21:00	GlobeNewswire Inc.	Soleno Therapeutics Announces Submission of New Drug Application to the U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets for the Treatment of Prader-Willi Syndrome	NASDAQ:SLNO	Soleno Therapeutics Inc